Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Biotechs Spar Over Algae

by Marc S. Reisch
March 9, 2015 | A version of this story appeared in Volume 93, Issue 10

Solazyme has asked a U.S. federal court to uphold an arbitration award of $2.3 million and intellectual property developed with former partner Roquette. The two had a joint venture, starting in 2010 but dissolved in 2013, to research and market microalgae-derived ingredients for human and animal consumption. Solazyme says the venture got under way with its intellectual property, which Roquette promised not to reverse-engineer but did. In addition to the arbitration award, Solzyme is asking the court for punitive damages and an order barring Roquette from using its intellectual property.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.